Goldman Sachs
CVAC

Goldman Sachs’s CureVac CVAC Stock Holding History

Goldman Sachs’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-399,893
Closed -$2.16M – 6498
2025
Q3 		$2.16M Sell
399,893
-33,965
-8% -$184K ﹤0.01% 4407
2025
Q2 		$2.36M Buy
433,858
+166,454
+62% +$660K ﹤0.01% 4046
2025
Q1 		$741K Sell
267,404
-75,941
-22% -$264K ﹤0.01% 4924
2024
Q4 		$1.17M Sell
343,345
-29,573
-8% -$85.3K ﹤0.01% 4700
2024
Q3 		$1.1M Sell
372,918
-22,183
-6% -$73.1K ﹤0.01% 4571
2024
Q2 		$1.34M Buy
395,101
+71,266
+22% +$233K ﹤0.01% 4245
2024
Q1 		$981K Sell
323,835
-45,955
-12% -$161K ﹤0.01% 4364
2023
Q4 		$1.56M Sell
369,790
-146,212
-28% -$793K ﹤0.01% 4109
2023
Q3 		$3.52M Buy
516,002
+50,212
+11% +$443K ﹤0.01% 3304
2023
Q2 		$4.85M Buy
465,790
+1,149
+0.2% +$10.3K ﹤0.01% 3133
2023
Q1 		$3.24M Buy
464,641
+248,870
+115% +$2.17M ﹤0.01% 3457
2022
Q4 		$1.3M Sell
215,771
-171,205
-44% -$1.26M ﹤0.01% 4256
2022
Q3 		$3.05M Sell
386,976
-278,294
-42% -$3.24M ﹤0.01% 3590
2022
Q2 		$9.05M Buy
665,270
+384,046
+137% +$6.35M ﹤0.01% 2607
2022
Q1 		$5.51M Sell
281,224
-61,533
-18% -$1.23M ﹤0.01% 3258
2021
Q4 		$11.8M Buy
342,757
+225,397
+192% +$9.07M ﹤0.01% 2610
2021
Q3 		$6.41M Buy
117,360
+44,467
+61% +$2.68M ﹤0.01% 3143
2021
Q2 		$5.36M Buy
72,893
+56,017
+332% +$5.6M ﹤0.01% 3283
2021
Q1 		$1.54M Buy
16,876
+5,385
+47% +$522K ﹤0.01% 4248
2020
Q4 		$932K Buy
11,491
+4,570
+66% +$350K ﹤0.01% 4242
2020
Q3 		$322K Buy
+6,921
New +$386K ﹤0.01% 4700

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Goldman Sachs's CVAC Position: Q4 2025 in Review

Goldman Sachs sold out of CureVac (CVAC) in Q4 2025, closing a stake of 399,893 shares — an estimated $2.16M sold.

Goldman Sachs first reported a position in CVAC in Q3 2020 and held it in 21 quarters. The position peaked at $11.8M in Q4 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Goldman Sachs reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Goldman Sachs sold 399,893 CureVac shares in Q4 2025, an estimated $2.16M.
  • Goldman Sachs first reported a position in CureVac in Q3 2020 and held it in 21 quarters.
  • Goldman Sachs's CureVac position peaked at $11.8M in Q4 2021.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.